Ebtisam Alosimi
Papers
1
Total Citations
4
H-Index
1
About
Dr. Ebtisam Alosimi is a pioneering researcher at the intersection of neuropharmacology, developmental neuroscience, and advanced biofabrication. Her work centers on understanding how widely prescribed neurological drugs affect early neuronal development, with a particular focus on embryonic cortical neurons. Dr. Alosimi's major contribution lies in her innovative use of ultrashort self-assembling peptides to create sophisticated three-dimensional (3D) neuronal culture models. By integrating these biomaterials with in-house developed high-throughput robotic 3D bioprinting, she has established a powerful platform for assessing drug safety during critical developmental windows. Her most cited study (2024, 4 citations) investigates the effects of pregabalin—a common medication for neurological disorders—on embryonic brain development, addressing a critical gap in prenatal pharmacology. This work demonstrates her commitment to translating advanced tissue engineering into clinically relevant neurotoxicity screening. Dr. Alosimi’s research not only advances our understanding of drug-induced developmental neurotoxicity but also sets a new standard for high-content, physiologically relevant in vitro models, making her a rising leader in the field of neurodevelopmental toxicology and 3D bioprinting.
Research Focus
Key Achievements
Top Papers
- 1